Skip to main content

Table 1 Summary of reported cases of Brevundimonas vesicularis infection in humans

From: Case report: Infective endocarditis caused by Brevundimonas vesicularis

Reference

Age (y)/sex

Underlying disease

Clinical presentation

Treatment/duration

Outcome

(8)/NI

54/F

SLE, autoimmune hepatitis, steroid therapy

Necrotizing cellulitis

Tobramycin + ceftazidime/30d

Survival

(9)/NI

42/F

Mitral valve stenosis s/p mitral valve replacement

Septicaemia

Piperacillin - tazobactam/14d

Survival

(10)/CA

5/M

Sickle cell anemia

Pneumonia

Ceftriaxone + gentamicin/10d

Survival

(11)/NI

59–67/both

Hemodialysis

Septicaemia

Cefotaxime + tobramycin/unknown

Survival

(12)/CA

60/M

Trauma

Botryomycosis

Cefuroxime- axetil/4 months

Survival

(13)/CA

38/M

No

Acute tonsillitis

amoxicillin- clavulanate/3d

Survival

(14)/CA

1.25/F

No

Septic arthritis

cefuroxime/12d + oral cephalexin/14d

Survival

(15)/CA

55/M

Continuous ambulatory peritoneal dialysis

peritonitis

ceftazidime/3d, ceftazidime + vancomycin/4d, ciprofloxacin + aztreonam/14d

Survival

current case/CA

40/M

No

Subacute endocarditis

cefazolin + gentamicin/3 d, Ampicillin/sulbactam + gentamicin/5 d, Ceftriaxone + gentamicin/7 d, ciprofloxacin/30 d

Survival

  1. Abbreviations:
  2. CA = community-acquired infection;
  3. NI: nosocomial infection. Nosocomial infections are those that originate or occur in a hospital if they first appear 48 hours or more after admission or hospital-like settings.